Page last updated: 2024-10-21

pk 11195 and Melanoma

pk 11195 has been researched along with Melanoma in 1 studies

PK-11195 : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 1-(2-chlorophenyl)isoquinoline-3-carboxylic acid with the amino group of sec-butylmethylamine

Melanoma: A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gyrylova, SN1
Ruksha, TG1
Komina, AV1

Other Studies

1 other study available for pk 11195 and Melanoma

ArticleYear
[TSPO ligand PK11195 and MAPK inhibitor UO126 modulate tspo expression level].
    Tsitologiia, 2013, Volume: 55, Issue:2

    Topics: Butadienes; Cell Line, Tumor; Gene Expression Regulation, Neoplastic; Humans; Isoquinolines; MAP Kin

2013